Monthly changes in serum levels of S100B protein as a predictor of metastasis development in high-risk melanoma patients.
Sümeyre Seda ErtekinSebastian PodlipnikSimone RiberoR MolinaJ RiosCristina CarreraJosep Malvehy GuileraSusana Puig SardàPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
During follow-up of high-risk melanoma patients, rising serum S100B values within the normal range can be an important clue to disease progression.